BTSG vs. ESLA

Last updated Apr 1, 2026

Compare and contrast key facts about BrightSpring Health Services, Inc (BTSG) and Estrella Immunopharma Inc. (ESLA).

Performance

BTSG vs. ESLA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BrightSpring Health Services, Inc (BTSG) and Estrella Immunopharma Inc. (ESLA). The values are adjusted to include any dividend payments, if applicable.

BTSG vs. ESLA - Yearly Performance Comparison

	2026 (YTD)	2025	2024
BTSG BrightSpring Health Services, Inc	13.78%	119.91%	54.82%
ESLA Estrella Immunopharma Inc.	-32.05%	30.00%	-1.65%

Fundamentals

Market Cap BTSG : $9.36B ESLA : $40.25M
EPS BTSG : $0.87 ESLA : -$0.35
Total Revenue (TTM) BTSG : $12.91B ESLA : $0.00
Gross Profit (TTM) BTSG : $1.52B ESLA : $0.00
EBITDA (TTM) BTSG : $459.53M ESLA : -$13.06M

Returns By Period

In the year-to-date period, BTSG achieves a 13.78% return, which is significantly higher than ESLA's -32.05% return.

BTSG

• 1D: 2.58%
• 1M: 2.85%
• YTD: 13.78%
• 6M: 44.15%
• 1Y: 135.54%
• 3Y*: —
• 5Y*: —
• 10Y*: —

ESLA

• 1D: 2.91%
• 1M: -13.11%
• YTD: -32.05%
• 6M: -7.83%
• 1Y: 14.35%
• 3Y*: -53.55%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

BTSG vs. ESLA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BTSG

BTSG Risk / Return Rank: 96
BTSG Sharpe Ratio Rank: 97
BTSG Sortino Ratio Rank: 95
BTSG Omega Ratio Rank: 93
BTSG Calmar Ratio Rank: 96
BTSG Martin Ratio Rank: 97

ESLA

ESLA Risk / Return Rank: 49
ESLA Sharpe Ratio Rank: 46
ESLA Sortino Ratio Rank: 55
ESLA Omega Ratio Rank: 53
ESLA Calmar Ratio Rank: 47
ESLA Martin Ratio Rank: 46

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BTSG vs. ESLA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BrightSpring Health Services, Inc (BTSG) and Estrella Immunopharma Inc. (ESLA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BTSG	ESLA	Difference
Sharpe ratio Return per unit of total volatility	3.06	0.13	+2.93
Sortino ratio Return per unit of downside risk	3.59	1.01	+2.58
Omega ratio Gain probability vs. loss probability	1.45	1.12	+0.33
Calmar ratio Return relative to maximum drawdown	6.57	0.21	+6.35
Martin ratio Return relative to average drawdown	19.92	0.41	+19.51
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BTSG vs. ESLA - Sharpe Ratio Comparison

The current BTSG Sharpe Ratio is 3.06, which is higher than the ESLA Sharpe Ratio of 0.13. The chart below compares the historical Sharpe Ratios of BTSG and ESLA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	BTSG	ESLA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	3.06	0.13	+2.93
Sharpe Ratio (All Time) Calculated using the full available price history	1.97	-0.29	+2.26

Correlation

The correlation between BTSG and ESLA is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

BTSG vs. ESLA - Dividend Comparison

Neither BTSG nor ESLA has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

BTSG vs. ESLA - Drawdown Comparison

The maximum BTSG drawdown since its inception was -35.56%, smaller than the maximum ESLA drawdown of -96.58%. Use the drawdown chart below to compare losses from any high point for BTSG and ESLA.

Drawdown Indicators

	BTSG	ESLA	Difference
Max Drawdown Largest peak-to-trough decline	-35.56%	-96.58%	+61.02%
Max Drawdown (1Y) Largest decline over 1 year	-20.75%	-70.13%	+49.38%
Current Drawdown Current decline from peak	-4.93%	-95.01%	+90.08%
Average Drawdown Average peak-to-trough decline	-7.59%	-53.93%	+46.34%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.84%	36.54%	-29.70%

Volatility

BTSG vs. ESLA - Volatility Comparison

The current volatility for BrightSpring Health Services, Inc (BTSG) is 15.81%, while Estrella Immunopharma Inc. (ESLA) has a volatility of 18.45%. This indicates that BTSG experiences smaller price fluctuations and is considered to be less risky than ESLA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BTSG	ESLA	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.81%	18.45%	-2.64%
Volatility (6M) Calculated over the trailing 6-month period	29.00%	91.86%	-62.86%
Volatility (1Y) Calculated over the trailing 1-year period	44.50%	108.86%	-64.36%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	44.16%	135.37%	-91.21%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	44.16%	135.37%	-91.21%

Financials